Company: SCLXW
Filing Date: 2025-08-04
Form Type: S-1
Source: 0001193125-25-172703
Chunk: 197

Company: Scilex Holding Co
Filing Date: 2025-08-04
Form: S-1
Chunk 197
---
 June 2024 in the principal amount of $10.0 million and was satisfied in November 2024 by the delivery of the Additional Product (as defined below) to Endeavor. The Tranche B Notes were issued in October 2024 in the principal amount of $50.0 million, of which the principal amount of $38.0 million remained outstanding as of December 31, 2024.

Interest Expense, Net

Interest expense, net for the years ended December 31, 2024 and 2023 was $2.0 million and $1.1 million, respectively. The increase was attributed to $0.8 million of interest related to the Revolving Facility and $0.1 million of interest related to deferred consideration for GLOPERBA license acquired from Romeg in 2022.**

<div align='center'>126</div>

Liquidity and Capital Resources As of March 31, 2025, we had cash and cash equivalents of approximately $5.8 million. We have funded our operations primarily through the financing pursuant to the ATM Sales Agreement (as defined below). We also have indebtedness pursuant to the Oramed Note and Tranche B Notes as well as deferred consideration related to the GLOPERBA license acquired from Romeg in 2022. The following table summarizes the aggregate indebtedness of these issuances as of March 31, 2025, December 31, 2024, and December 31, 2023 (in thousands):

| Oramed Note (outstanding principal balance: $25.7 million, $25.0 million, and $100.9 million as of March 31, 2025, December 31, 2024 and 2023, respectively)    |     | March 31, 
 2025      | 14,962 |     | December 31, 
 2024         | 12,161 |     | December 31, 
 2023         | 104,089 |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:----------|-------:|:----|:-------------|-------:|:----|:-------------|--------:|
| Convertible Debentures (outstanding principal balance: nil, nil, and $4.4 million as of March 31, 2025, December 31, 2024 and 2023, respectively)               |     |           |      — |     |              |      — |     |